ALK-Abello A/S Stock

ALK-Abello A/S Employees 2024

ALK-Abello A/S Employees

2,404

Ticker

ALK B.CO

ISIN

DK0060027142

WKN

A0H0J1

In 2024, ALK-Abello A/S employed 2,404 people, a 0% change from the 2,404 number of employees in the previous year.

ALK-Abello A/S Aktienanalyse

What does ALK-Abello A/S do?

ALK-Abello A/S is a Danish company specializing in the production of allergy-based products and therapies. It was founded in 1923 by Dr. H. C. Harald Petersen and is headquartered in Hørsholm, Denmark. The company's history began with Dr. Petersen's discovery that allergens could be administered to trigger an immune reaction in a control system. He developed a therapy for hay fever using pollen extracts from grasses, flowers, and trees to desensitize the immune system to these allergens. In 1940, ALK introduced the first specific immunotherapy (SIT) for protection against pollen allergies. ALK-Abello A/S is a leading provider of allergen-based therapeutics and diagnostic tests for allergic diseases. The company offers two main products: allergen immunotherapies and diagnostic tests for allergic diseases. These products are offered in 28 countries worldwide, and the company is the largest provider of allergen-based therapeutics in Europe. ALK-Abello A/S operates three main divisions: allergen immunotherapies, diagnostic products, and other specialty products. The allergen immunotherapies are based on allergen extracts and aim to train the immune system to tolerate allergens by administering a small amount that is enough to trigger an immune response but not cause an allergic reaction. These therapies are used for various allergic diseases, including hay fever, asthma, and allergic skin conditions. The diagnostic products of ALK-Abello A/S are used for the diagnosis of allergic diseases. There are different types of diagnostic tests, including skin tests, in vitro diagnostic tests, and specific IgE tests (blood tests). Other specialty products of ALK-Abello A/S include products for the treatment of specific allergies or diseases related to allergies. Examples include adrenaline auto-injectors for the treatment of anaphylactic shock and nasal sprays for the treatment of hay fever. In summary, ALK-Abello A/S is a leading provider of allergy products and therapies, with a long history in the development of allergen-based therapeutics. The company operates three main divisions and offers a wide range of products that can be used for the diagnosis and treatment of allergic diseases. ALK-Abello A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining ALK-Abello A/S's Employee Base

ALK-Abello A/S's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding ALK-Abello A/S's operational capacity and future potential.

Year-to-Year Comparison

Assessing ALK-Abello A/S's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

ALK-Abello A/S's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in ALK-Abello A/S’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about ALK-Abello A/S stock

How many employees does ALK-Abello A/S have this year?

ALK-Abello A/S has 2,404 undefined employees this year.

How many employees did ALK-Abello A/S have compared to the previous year?

Compared to the previous year, ALK-Abello A/S had 0% more employees.

What impact did the number of employees have on the company ALK-Abello A/S?

The number of employees has a direct impact on the efficiency and productivity of ALK-Abello A/S. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of ALK-Abello A/S?

The number of employees can also have an impact on investors of ALK-Abello A/S, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of ALK-Abello A/S affect the company?

An increase in equity of ALK-Abello A/S can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in ALK-Abello A/S's equity affect the company?

A reduction in equity of ALK-Abello A/S can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of ALK-Abello A/S?

Some factors that can influence the equity of ALK-Abello A/S include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of ALK-Abello A/S so important for investors?

The equity of ALK-Abello A/S is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at ALK-Abello A/S influence the company?

The number of employees at ALK-Abello A/S can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at ALK-Abello A/S evolved in recent years?

In recent years, the number of employees at ALK-Abello A/S has changed by 0.

How many employees does ALK-Abello A/S currently have?

ALK-Abello A/S currently has 2,404 undefined employees.

Why is the number of employees important for investors of ALK-Abello A/S?

The number of employees is important for investors of ALK-Abello A/S as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can ALK-Abello A/S take to change the number of employees?

To change the number of employees, ALK-Abello A/S can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does ALK-Abello A/S pay?

Over the past 12 months, ALK-Abello A/S paid a dividend of 5 DKK . This corresponds to a dividend yield of about 3.02 %. For the coming 12 months, ALK-Abello A/S is expected to pay a dividend of 0 DKK.

What is the dividend yield of ALK-Abello A/S?

The current dividend yield of ALK-Abello A/S is 3.02 %.

When does ALK-Abello A/S pay dividends?

ALK-Abello A/S pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of ALK-Abello A/S?

ALK-Abello A/S paid dividends every year for the past 6 years.

What is the dividend of ALK-Abello A/S?

For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.

In which sector is ALK-Abello A/S located?

ALK-Abello A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von ALK-Abello A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ALK-Abello A/S from 3/20/2017 amounting to 5 DKK, you needed to have the stock in your portfolio before the ex-date on 3/16/2017.

When did ALK-Abello A/S pay the last dividend?

The last dividend was paid out on 3/20/2017.

What was the dividend of ALK-Abello A/S in the year 2023?

In the year 2023, ALK-Abello A/S distributed 0 DKK as dividends.

In which currency does ALK-Abello A/S pay out the dividend?

The dividends of ALK-Abello A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ALK-Abello A/S

Our stock analysis for ALK-Abello A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ALK-Abello A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.